HCPCS Level IIdrugActive
J9041
Injection, bortezomib, 0.1mg
BETOS: O1D
Effective: 2023-01-01
Referenced in 1 policies
Description
Injection, bortezomib, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Bortezomib
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
0.1 MG
Billing Units
35.0000
20
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.